Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Sirolimus, also known as rapamycin and sold under the brand name Rapamune among others, is a macrolide compound that is used to coat coronary stents, prevent organ transplant rejection, treat a rare lung disease called lymphangioleiomyomatosis, and treat perivascular epithelioid cell tumour (PEComa). It has immunosuppressant functions in humans and is…
The analysis highlights Community, Culture, Applications and Research as prominent areas in the source structure around Sirolimus.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
The extracted context around Sirolimus shows recurring relationship patterns in the source. For example, Sirolimus → CYP2C8, CYP3A4, CYP3A5, Dose-corrected, Drug, However, In, It, P-glycoprotein, P-gp, PK, SRL, TAC, The, This Another extracted example is Sirolimus → August, Committee, European Medicines Agency, European Union, GmbH, Human Use, Hyftor, In February, May, Medicinal Products, Plusultra, Rapamune, The, United States. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
rapamycin treatment mtor patients use disease clinical also studies may effects transplant drug risk first complex calcineurin used however approved
TTTA extracted 159 structured relationships around Sirolimus. Examples in this analysis include Sirolimus → 3D model (JSmol) → Interactive image and Sirolimus → ATC code → L04AH01 (WHO) L01EG04 (WHO), S01XA23 (WHO), QC01EB90 (WHO). The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Sirolimus | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Sirolimus | ATC code | L04AH01 (WHO) L01EG04 (WHO), S01XA23 (WHO), QC01EB90 (WHO) | 1.00 | infobox |
| Sirolimus | Bioavailability | 14% (oral solution), lower with high-fat meals; 18% (tablet), higher with high-fat meals | 1.00 | infobox |
| Sirolimus | CAS Number | 53123–88–9 Y | 1.00 | infobox |
| Sirolimus | ChEBI | CHEBI:9168 Y | 1.00 | infobox |
| Sirolimus | ChEMBL | ChEMBL413 Y | 1.00 | infobox |
| Sirolimus | ChemSpider | 10482078 Y | 1.00 | infobox |
| Sirolimus | CompTox Dashboard (EPA) | DTXSID5023582 | 1.00 | infobox |
| Sirolimus | DrugBank | DB00877 Y | 1.00 | infobox |
| Sirolimus | ECHA InfoCard | 100.107.147 | 1.00 | infobox |
| Sirolimus | Elimination half-life | 57–63 hours | 1.00 | infobox |
| Sirolimus | Excretion | Mostly fecal | 1.00 | infobox |
| Sirolimus | Formula | C51H79NO13 | 1.00 | infobox |
| Sirolimus | KEGG | D00753 Y | 1.00 | infobox |
| Sirolimus | Legal status | US: ℞-only | 1.00 | infobox |
| Sirolimus | Legal status | EU: Rx-only | 1.00 | infobox |
| Sirolimus | License data | US DailyMed: Sirolimus | 1.00 | infobox |
| Sirolimus | Metabolism | Liver | 1.00 | infobox |
| Sirolimus | Molar mass | 914.187 g·mol−1 | 1.00 | infobox |
| Sirolimus | Other names | Rapamycin, ABI-009 | 1.00 | infobox |
| Sirolimus | PDB ligand | RAP (PDBe, RCSB PDB) | 1.00 | infobox |
| Sirolimus | Pregnancy category | AU: C | 1.00 | infobox |
| Sirolimus | Protein binding | 92% | 1.00 | infobox |
| Sirolimus | PubChem CID | 5284616 | 1.00 | infobox |
| Sirolimus | Routes of administration | By mouth, intravenous, topical | 1.00 | infobox |
| Sirolimus | Solubility in water | 0.0026 | 1.00 | infobox |
| Sirolimus | Trade names | Rapamune, others | 1.00 | infobox |
| Sirolimus | UNII | W36ZG6FT64 | 1.00 | infobox |
| Sirolimus | is a | relatively new medical therapy for the treatment of vascular malformations in recent years | 0.90 | text |
| Sirolimus | is a | natural product and macrocyclic lactone.BiosynthesisThe biosynthesis of the rapamycin core is accomplished by a type I polyketide synthase | 0.90 | text |
The concept neighborhoods around Sirolimus bring nearby vocabulary together. In this analysis, examples include Treatment, Transplant and Risk. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Sirolimus, one of the stronger structural bridges in this analysis connects Sirolimus with Research. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Sirolimus to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as Community, Culture, Applications & Research, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Sirolimus · EN edition · Analysis: TopicsToTalkAbout